Why did I seek more?
Knowing that there was a test that could help resolve an indeterminate diagnosis meant the world to me. I would do just about anything to avoid surgery and I trusted my doctor.
Real People
Knowing
Real Answers.
KAREN MELMED
Afirma Patient
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Answers That Set New Standards
Veracyte’s CEO named as one of 2017’s Fiercest Women in Life Sciences

learn more >


latest news
news and updates
Sep 5, 2018
Bonnie Anderson, Veracyte CEO, speaks with Bill Vick of PF Warriors about Envisia Genomic Classifier

learn more >
Jul 25, 2018
Veracyte CEO Says RNA Sequencing Data Will Drive Future Pharma Deals, Products

learn more >
May 29, 2018
Novel Genomic Sequence Classifier Improves Detection of Benign Thyroid Nodules

learn more >